Molnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of mild-to-moderate Covid -19 in adults, and is under review by the US Food and Drug Administration.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3HiaJji
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Drug cos including, Sun Pharma, awaiting regulator nod to launch Covid-19 drug in India
https://ift.tt/eA8V8J
No comments:
Post a Comment